|
IFT80 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.12119999973982E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00509999999099E-05 |
| Normal-vs-Stage2 |
1.697690E-02 |
| Normal-vs-Stage3 |
1.3488000000228E-06 |
| Normal-vs-Stage4 |
2.010300E-04 |
| Stage1-vs-Stage2 |
7.227400E-01 |
| Stage1-vs-Stage3 |
1.389550E-01 |
| Stage1-vs-Stage4 |
6.926600E-01 |
| Stage2-vs-Stage3 |
2.512400E-01 |
| Stage2-vs-Stage4 |
5.735400E-01 |
| Stage3-vs-Stage4 |
4.167600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44440000005019E-06 |
| Normal-vs-AfricanAmerican |
2.458400E-03 |
| Normal-vs-Asian |
9.426100E-02 |
| Caucasian-vs-AfricanAmerican |
7.277000E-01 |
| Caucasian-vs-Asian |
8.372600E-01 |
| AfricanAmerican-vs-Asian |
7.116200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.54719999987141E-07 |
| Normal-vs-Female |
2.954200E-04 |
| Male-vs-Female |
9.293600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.555500E-04 |
| Normal-vs-Age(41-60Yrs) |
7.017100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.40149999999984E-06 |
| Normal-vs-Age(81-100Yrs) |
9.424800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.756350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.293600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.377200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.162200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.720400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.670400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.159000E-01 |
| Normal-vs-Grade 2 |
1.641340E-03 |
| Normal-vs-Grade 3 |
1.95848999999804E-05 |
| Normal-vs-Grade 4 |
2.56950000165901E-08 |
| Grade 1-vs-Grade 2 |
2.251000E-01 |
| Grade 1-vs-Grade 3 |
1.408160E-02 |
| Grade 1-vs-Grade 4 |
6.647900E-04 |
| Grade 2-vs-Grade 3 |
1.107780E-01 |
| Grade 2-vs-Grade 4 |
3.038100E-04 |
| Grade 3-vs-Grade 4 |
5.815400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.181400E-03 |
| Normal-vs-ccB subtype |
5.10360000038901E-07 |
| ccA subtype-vs-ccB subtype |
2.783200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.836430E-04 |
| Normal-vs-N1 |
3.718100E-03 |
| N0-vs-N1 |
5.622400E-01 |
|
|
